174 related articles for article (PubMed ID: 2987427)
1. Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU.
Kapp JP; Vance RB
J Neurooncol; 1985; 3(1):5-11. PubMed ID: 2987427
[TBL] [Abstract][Full Text] [Related]
2. Supraophthalmic carotid infusion with low dose cisplatin and BCNU for malignant glioma.
Vance RB; Kapp JP
J Neurooncol; 1986; 3(4):287-90. PubMed ID: 3958775
[TBL] [Abstract][Full Text] [Related]
3. Effect of intra-arterial cisplatin and 1,3-bis(2chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: proposal of a new method of intra-arterial dosage calculation.
Bobo H; Kapp JP; Vance R
J Neurooncol; 1992 Jul; 13(3):291-9. PubMed ID: 1517805
[TBL] [Abstract][Full Text] [Related]
4. Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors.
Stewart DJ; Grahovac Z; Benoit B; Addison D; Richard MT; Dennery J; Hugenholtz H; Russell N; Peterson E; Maroun JA
Neurosurgery; 1984 Dec; 15(6):828-33. PubMed ID: 6392925
[TBL] [Abstract][Full Text] [Related]
5. The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma.
Hochberg FH; Pruitt AA; Beck DO; DeBrun G; Davis K
J Neurosurg; 1985 Dec; 63(6):876-80. PubMed ID: 2997415
[TBL] [Abstract][Full Text] [Related]
6. Neurological deficit after carotid infusion of cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) for malignant glioma: an analysis of risk factors.
Kapp JP; Sanford RA
Neurosurgery; 1986 Nov; 19(5):779-83. PubMed ID: 3785625
[TBL] [Abstract][Full Text] [Related]
7. Supraophthalmic carotid infusion for brain chemotherapy. Experience with a new single-lumen catheter and maneuverable tip.
Kapp JP; Parker JL; Tucker EM
J Neurosurg; 1985 Jun; 62(6):823-5. PubMed ID: 4039751
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of supratentorial glioma with intracarotid cisplatin and intravenous carmustine].
Rebollo J; Martín-Algarra S; Bilbao I; Zubieta JL; Calvo FA; de Castro P; Pastor MA; Viteri C; Martínez Lage JM
Neurologia; 1990; 5(7):228-32. PubMed ID: 1963067
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumors.
Feun LG; Lee YY; Yung WK; Charnsangavej C; Savaraj N; Tang RA; Wallace S
Cancer Drug Deliv; 1986; 3(2):147-56. PubMed ID: 3708537
[TBL] [Abstract][Full Text] [Related]
10. Treatment of recurrent brain tumors with intra-arterial cis-platinum and BCNU.
Kapp JP; Vance R
J Miss State Med Assoc; 1984 Jan; 25(1):1-6. PubMed ID: 6325705
[No Abstract] [Full Text] [Related]
11. Optic nerve degeneration caused by supraophthalmic carotid artery infusion with cisplatin and ACNU. Case report.
Shimamura Y; Chikama M; Tanimoto T; Kawakami Y; Tsutsumi A
J Neurosurg; 1990 Feb; 72(2):285-8. PubMed ID: 2295924
[TBL] [Abstract][Full Text] [Related]
12. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study.
West CR; Avellanosa AM; Barua NR; Patel A; Hong CI
Neurosurgery; 1983 Oct; 13(4):420-6. PubMed ID: 6314173
[TBL] [Abstract][Full Text] [Related]
13. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.
Liau CT; Wei KC; Tseng CK; Jung SM
Chang Gung Med J; 2005 Jan; 28(1):16-23. PubMed ID: 15804144
[TBL] [Abstract][Full Text] [Related]
15. Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas.
Miller DF; Bay JW; Lederman RJ; Purvis JD; Rogers LR; Tomsak RL
Ophthalmology; 1985 Mar; 92(3):402-6. PubMed ID: 2986069
[TBL] [Abstract][Full Text] [Related]
16. Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors.
Bremer AM; Kleriga E; Nguyen TQ; Balsys R; Northup HM; Gonzalez N; Duarte P; Miller RI
J Neurooncol; 1984; 2(2):129-32. PubMed ID: 6481425
[TBL] [Abstract][Full Text] [Related]
17. Pre-irradiation internal carotid artery BCNU in treatment of glioblastoma multiforme.
Bashir R; Hochberg FH; Linggood RM; Hottleman K
J Neurosurg; 1988 Jun; 68(6):917-9. PubMed ID: 2836567
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of malignant gliomas: studies of the BTCG.
Shapiro WR
Rev Neurol (Paris); 1992; 148(6-7):428-34. PubMed ID: 1448662
[TBL] [Abstract][Full Text] [Related]
19. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.
Shapiro WR; Green SB; Burger PC; Selker RG; VanGilder JC; Robertson JT; Mealey J; Ransohff J; Mahaley MS
J Neurosurg; 1992 May; 76(5):772-81. PubMed ID: 1564540
[TBL] [Abstract][Full Text] [Related]
20. Alternating sequential intracarotid BCNU and cisplatin in recurrent malignant glioma.
Rogers LR; Purvis JB; Lederman RJ; Rosenbloom SA; Tomsak RL; Estes ML; Magdinec M; Medendorp SV; Boyett JM
Cancer; 1991 Jul; 68(1):15-21. PubMed ID: 2049736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]